Th17细胞在非酒精性脂肪肝病炎症过程中的作用(5)
[22]Su SB，Chen W，Huang FF，et al.Elevated Th22 cells correlated with Th17 cells in patients with high liver stiffness in nonalcoholic fatty liver disease[J].European Journal of Inflammation，2018(16)：1927-1945.
[23]Lichen B，Jun Y，Wen G，et al.A long‐acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non‐alcoholic steatohepatitis partly through an FGF21‐adiponectin‐IL17A pathway[J].British Journal of Pharmacology，2018，175(16)：3379-3393.
[24]Roos AB，Sethi S，Nikota J，et al.IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].American Journal of Respiratory&Critical Care Medicine，2015，192(4)：428.
[25]Rau M，Rehman A，Dittrich M，et al.Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease[J].United European Gastroenterology Journal，2018，6(10)：205064061880444.
[26]Wu LY，Liu S，Liu Y，et al.Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C[J].Clin Immunol，2015，158(1)：77-87.
[27]Sapan HB，Paturusi I，Jusuf I，et al.Pattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome(MODS)in polytrauma[J].Int J Burns Trauma，2016，6(2)：37.
收稿日期：2020-06-17;修回日期：2020-06-27
編辑/钱洪飞, 百拇医药(潘婷 胡阳黔)
[23]Lichen B，Jun Y，Wen G，et al.A long‐acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non‐alcoholic steatohepatitis partly through an FGF21‐adiponectin‐IL17A pathway[J].British Journal of Pharmacology，2018，175(16)：3379-3393.
[24]Roos AB，Sethi S，Nikota J，et al.IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].American Journal of Respiratory&Critical Care Medicine，2015，192(4)：428.
[25]Rau M，Rehman A，Dittrich M，et al.Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease[J].United European Gastroenterology Journal，2018，6(10)：205064061880444.
[26]Wu LY，Liu S，Liu Y，et al.Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C[J].Clin Immunol，2015，158(1)：77-87.
[27]Sapan HB，Paturusi I，Jusuf I，et al.Pattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome(MODS)in polytrauma[J].Int J Burns Trauma，2016，6(2)：37.
收稿日期：2020-06-17;修回日期：2020-06-27
編辑/钱洪飞, 百拇医药(潘婷 胡阳黔)